UniProtKB/Swiss-Prot Q8WWV3: Variant p.Gly321Glu

NAD(P)H oxidoreductase RTN4IP1, mitochondrial
Gene: RTN4IP1
Feedback?

Variant information Variant position:

321 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Glutamate (E) at position 321 (G321E, p.Gly321Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In OPA10; uncertain significance. Any additional useful information about the variant.

Sequence information Variant position:

321 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

396 The length of the canonical sequence.
Location on the sequence:

VTPFLLNMDRLGIADGMLQT G VTVGSKALKHFWKGVHYRWA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VTPFLLNMDRLGIADGM---LQTGVTVGSKALKHFWKGVHYRWA

Mouse                         VTPFLLNMDRLGVADGM---LQTGVTVGTKALKHLWQGVHY

Bovine                        VTPFLLNMDRLGIADGM---LQTGVTVGSKTLKHFWQGVHY

Zebrafish                     ITPFLQNTDRLGLADGM---MQSAVTVGCKVVKNLRKGVHY

Caenorhabditis elegans        VSPLMREMDKNGVPLGL---VTTAMKHFERSFQSHLRGRWF

Slime mold                    NGPLVKFSDKDGVLSGLPMGMMNQLNSSERIKKQYSKNVHL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	41 – 396	NAD(P)H oxidoreductase RTN4IP1, mitochondrial
Domain	52 – 393	Enoyl reductase (ER)
Binding site	341 – 341
Alternative sequence	227 – 396	Missing. In isoform 3.
Helix	313 – 333

Literature citations
Neurologic Phenotypes Associated With Mutations in RTN4IP1 (OPA10) in Children and Young Adults.
Charif M.; Nasca A.; Thompson K.; Gerber S.; Makowski C.; Mazaheri N.; Bris C.; Goudenege D.; Legati A.; Maroofian R.; Shariati G.; Lamantea E.; Hopton S.; Ardissone A.; Moroni I.; Giannotta M.; Siegel C.; Strom T.M.; Prokisch H.; Vignal-Clermont C.; Derrien S.; Zanlonghi X.; Kaplan J.; Hamel C.P.; Leruez S.; Procaccio V.; Bonneau D.; Reynier P.; White F.E.; Hardy S.A.; Barbosa I.A.; Simpson M.A.; Vara R.; Perdomo Trujillo Y.; Galehdari H.; Deshpande C.; Haack T.B.; Rozet J.M.; Taylor R.W.; Ghezzi D.; Amati-Bonneau P.; Lenaers G.;
JAMA Neurol. 75:105-113(2018)
Cited for: VARIANTS OPA10 ILE-43; CYS-51; HIS-103; SER-105; 144-TRP--VAL-396 DEL; PHE-167; GLU-321; PRO-356 AND PHE-362;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.